1. Home
  2. Labeler Index
  3. Ani Pharmaceuticals, Inc.
  4. 62559-231
  5. NDC Package Code: 62559-231-01 Propafenone Hydrochloride

NDC Package 62559-231-01 Propafenone Hydrochloride

Tablet, Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
62559-231-01
Package Description:
100 TABLET, COATED in 1 BOTTLE
Product Code:
62559-231
Proprietary Name:
Propafenone Hydrochloride
Non-Proprietary Name:
Propafenone Hydrochloride
Substance Name:
Propafenone Hydrochloride
Usage Information:
Propafenone Hydrochloride Tablets USP are indicated to:•prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms in patients without structural heart disease.•prolong the time to recurrence of paroxysmal supraventricular tachycardia (PSVT) associated with disabling symptoms in patients without structural heart disease.•treat documented ventricular arrhythmias, such as sustained ventricular tachycardia that, in the judgment of the physician, are life-threatening. Initiate treatment in the hospital.Usage Considerations:•The use of Propafenone Hydrochloride Tablets USP in patients with permanent atrial fibrillation (AF) or in patients exclusively with atrial flutter or PSVT has not been evaluated. Do not use Propafenone Hydrochloride Tablets USP to control ventricular rate during AF.•Some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. Concomitant treatment with drugs that increase the functional atrioventricular (AV) nodal refractory period is recommended.•The use of Propafenone Hydrochloride Tablets USP in patients with chronic atrial fibrillation has not been evaluated.•Because of the proarrhythmic effects of Propafenone Hydrochloride Tablets USP, its use with lesser ventricular arrhythmias is not recommended, even if patients are symptomatic, and any use of the drug should be reserved for patients in whom, in the opinion of the physician, the potential benefits outweigh the risks.•The effect of propafenone on mortality has not been determined [see Boxed Warning].
11-Digit NDC Billing Format:
62559023101
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
100 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 861424 - propafenone HCl 150 MG Oral Tablet
  • RxCUI: 861424 - propafenone hydrochloride 150 MG Oral Tablet
  • RxCUI: 861427 - propafenone HCl 225 MG Oral Tablet
  • RxCUI: 861427 - propafenone hydrochloride 225 MG Oral Tablet
  • RxCUI: 861430 - propafenone HCl 300 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ani Pharmaceuticals, Inc.
    Dosage Form:
    Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • PROPAFENONE HYDROCHLORIDE 225 mg/1
    • Pharmacologic Class(es):
  • Antiarrhythmic - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA076550
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-31-2015
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 62559-231-01?

    The NDC Packaged Code 62559-231-01 is assigned to a package of 100 tablet, coated in 1 bottle of Propafenone Hydrochloride, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. The product's dosage form is tablet, coated and is administered via oral form.

    Is NDC 62559-231 included in the NDC Directory?

    Yes, Propafenone Hydrochloride with product code 62559-231 is active and included in the NDC Directory. The product was first marketed by Ani Pharmaceuticals, Inc. on March 31, 2015 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 62559-231-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 100.

    What is the 11-digit format for NDC 62559-231-01?

    The 11-digit format is 62559023101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-262559-231-015-4-262559-0231-01